CommentGuidelines for anticoagulant use in acute coronary syndromes
References (8)
- et al.
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J Am Coll Cardiol
(2007) - et al.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology
Eur Heart J
(2007) Methodology manual for ACC/AHA guideline writing committees
- et al.
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
JAMA
(2004)
Cited by (17)
GRADE Guidelines: 2. Framing the question and deciding on important outcomes
2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im GesundheitswesenGRADE guidelines: 2. Framing the question and deciding on important outcomes
2011, Journal of Clinical EpidemiologyCitation Excerpt :Sometimes, there are multiple comparators to an intervention, and this raises particular challenges. For example, the European Society of Cardiology makes recommendations for use of anticoagulants in patients with non-ST elevation acute coronary syndromes receiving conservative (noninvasive) management [5]. Fondaparinux receives a 1A, heparin a 1C, and enoxaparin a 2A/B. Presumably, these are recommendations for use of these agents vs. not using any anticoagulants.
The Year in Non-ST-Segment Elevation Acute Coronary Syndrome
2008, Journal of the American College of CardiologyCitation Excerpt :These guidelines are remarkably similar. However, they differ regarding the recommendations and level of evidence that support the use of 3 of the 4 anticoagulants (11) (Table 4),and also regarding the loading dose of clopidogrel. The ACC/AHA update gives a higher Level of Evidence (LOE) to UFH and enoxaparin (Class Ia), but lower LOE for fondaparinux in conservatively managed patients (Class Ib).
Clinical experts or methodologists to write clinical guidelines?
2009, The LancetGuidelines for anticoagulant use in acute coronary syndromes
2008, The LancetAntitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug
2016, ACS Applied Materials and Interfaces